# EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis

> **NCT00142233** · PHASE3 · COMPLETED · sponsor: **University Medicine Greifswald** · enrollment: 295 (actual)

## Conditions studied

- Pancreatitis

## Interventions

- **DIETARY_SUPPLEMENT:** ANTOX (vers.)1.2
- **DRUG:** Magnesium
- **OTHER:** Placebo ANTOX (vers)1.2
- **OTHER:** Placebo Magnesiocard (2.5 mmol)

## Key facts

- **NCT ID:** NCT00142233
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-06
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142233, "EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00142233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*